Free Trial

Embecta Corp. (NASDAQ:EMBC) Shares Acquired by Teacher Retirement System of Texas

Embecta logo with Medical background
Remove Ads

Teacher Retirement System of Texas boosted its position in shares of Embecta Corp. (NASDAQ:EMBC - Free Report) by 349.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 55,708 shares of the company's stock after purchasing an additional 43,300 shares during the period. Teacher Retirement System of Texas owned approximately 0.10% of Embecta worth $1,150,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Smartleaf Asset Management LLC lifted its stake in shares of Embecta by 175.1% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,216 shares of the company's stock valued at $25,000 after purchasing an additional 774 shares during the last quarter. Quarry LP purchased a new stake in Embecta in the 3rd quarter valued at about $30,000. Oppenheimer Asset Management Inc. acquired a new position in Embecta in the fourth quarter valued at about $209,000. Intech Investment Management LLC acquired a new stake in shares of Embecta during the third quarter valued at about $211,000. Finally, Wilmington Savings Fund Society FSB purchased a new stake in shares of Embecta in the 3rd quarter valued at approximately $217,000. 93.83% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Embecta

In other news, Director Milton Mayo Morris sold 3,100 shares of the company's stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $16.38, for a total transaction of $50,778.00. Following the sale, the director now owns 36,133 shares of the company's stock, valued at approximately $591,858.54. This represents a 7.90 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.42% of the company's stock.

Remove Ads

Embecta Price Performance

Shares of NASDAQ:EMBC traded down $0.11 during mid-day trading on Wednesday, reaching $12.52. 466,591 shares of the company were exchanged, compared to its average volume of 441,177. Embecta Corp. has a 1 year low of $9.93 and a 1 year high of $21.48. The firm's 50-day simple moving average is $14.90 and its 200 day simple moving average is $16.20. The firm has a market cap of $727.84 million, a price-to-earnings ratio of 12.52, a P/E/G ratio of 0.78 and a beta of 1.27.

Embecta (NASDAQ:EMBC - Get Free Report) last released its quarterly earnings results on Thursday, February 6th. The company reported $0.65 EPS for the quarter, topping the consensus estimate of $0.45 by $0.20. Embecta had a negative return on equity of 19.22% and a net margin of 5.25%. On average, research analysts forecast that Embecta Corp. will post 2.85 earnings per share for the current fiscal year.

Embecta Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Friday, February 28th were paid a dividend of $0.15 per share. The ex-dividend date of this dividend was Friday, February 28th. This represents a $0.60 dividend on an annualized basis and a yield of 4.79%. Embecta's dividend payout ratio (DPR) is presently 60.00%.

Embecta Company Profile

(Free Report)

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.

Further Reading

Institutional Ownership by Quarter for Embecta (NASDAQ:EMBC)

Should You Invest $1,000 in Embecta Right Now?

Before you consider Embecta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Embecta wasn't on the list.

While Embecta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

These Are the 3 Stocks Most Likely to SPLIT in 2025

These Are the 3 Stocks Most Likely to SPLIT in 2025

MarketBeat analyst Thomas Hughes breaks down why companies split their stock and reveals his top three picks most likely to split next year.

Related Videos

Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
Elon Musk’s First 100 Days of DOGE: 3 AI Stocks Ready to Soar
5 Stocks to BUY NOW in February 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads